EUR 2.47
(0.61%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 3.5 Million EUR | 205.54% |
2022 | -3.32 Million EUR | 84.59% |
2021 | -21.56 Million EUR | -80.45% |
2020 | -11.94 Million EUR | -76.47% |
2019 | -6.77 Million EUR | 46.84% |
2018 | -12.73 Million EUR | 54.97% |
2017 | -28.28 Million EUR | 31.54% |
2016 | -41.31 Million EUR | -43.25% |
2015 | -28.84 Million EUR | -93.67% |
2014 | -14.89 Million EUR | -1206.54% |
2013 | -1.13 Million EUR | 0.0% |
2012 | - EUR | 100.0% |
2011 | -7.73 Million EUR | -1316.76% |
2010 | 635.79 Thousand EUR | -35.3% |
2009 | 982.71 Thousand EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 15.24 Million EUR | 0.0% |
2023 Q2 | 10.22 Million EUR | 0.0% |
2023 FY | 3.5 Million EUR | 205.54% |
2023 Q4 | 3.5 Million EUR | 0.0% |
2022 FY | -3.32 Million EUR | 84.59% |
2022 Q2 | -10.49 Million EUR | 0.0% |
2022 Q4 | -3.32 Million EUR | 0.0% |
2021 Q2 | -20.89 Million EUR | 0.0% |
2021 Q4 | -21.56 Million EUR | 0.0% |
2021 FY | -21.56 Million EUR | -80.45% |
2020 Q4 | -11.94 Million EUR | 0.0% |
2020 FY | -11.94 Million EUR | -76.47% |
2020 Q2 | -3.07 Million EUR | 0.0% |
2019 Q4 | -6.77 Million EUR | 0.0% |
2019 Q2 | -6.65 Million EUR | 0.0% |
2019 FY | -6.77 Million EUR | 46.84% |
2018 FY | -12.73 Million EUR | 54.97% |
2018 Q4 | -12.73 Million EUR | 0.0% |
2018 Q2 | -18.47 Million EUR | 0.0% |
2017 Q2 | -35.31 Million EUR | 0.0% |
2017 FY | -28.28 Million EUR | 31.54% |
2017 Q4 | -28.28 Million EUR | 0.0% |
2016 FY | -41.31 Million EUR | -43.25% |
2016 Q4 | -41.31 Million EUR | 0.0% |
2016 Q2 | -25.56 Million EUR | 0.0% |
2015 Q4 | -28.84 Million EUR | 0.0% |
2015 Q2 | -11.04 Million EUR | 0.0% |
2015 FY | -28.84 Million EUR | -93.67% |
2014 Q4 | -14.89 Million EUR | 0.0% |
2014 FY | -14.89 Million EUR | -1206.54% |
2014 Q2 | -233 Thousand EUR | 0.0% |
2013 Q2 | 977 Thousand EUR | 0.0% |
2013 FY | -1.13 Million EUR | 0.0% |
2013 Q4 | -1.13 Million EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 Q2 | 1.12 Million EUR | 0.0% |
2012 FY | - EUR | 100.0% |
2011 Q4 | -7.73 Million EUR | 0.0% |
2011 FY | -7.73 Million EUR | -1316.76% |
2010 FY | 635.79 Thousand EUR | -35.3% |
2009 FY | 982.71 Thousand EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Affluent Medical SA | 15.47 Million EUR | 77.346% |
Bluelinea Société Anonyme | -870.82 Thousand EUR | 502.606% |
Carmat SA | 49.63 Million EUR | 92.937% |
Diagnostic Medical Systems S.A. | 11.52 Million EUR | 69.587% |
Euromedis Groupe | -8.82 Million EUR | 139.723% |
Eurobio Scientific Société anonyme | 51.33 Million EUR | 93.17% |
Ikonisys S.A. | 3.19 Million EUR | -9.628% |
Implanet S.A. | 5.9 Million EUR | 40.606% |
SpineGuard SA | 215.79 Thousand EUR | -1524.675% |
Theraclion SA | -5.86 Million EUR | 159.783% |
Euroapi S.A. | 191 Million EUR | 98.164% |
Guerbet SA | 332.59 Million EUR | 98.946% |